KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$153.0 million.

  • Elanco Animal Health's Cash from Financing Activities rose 8858.21% to -$153.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$289.0 million, marking a year-over-year increase of 8192.62%. This contributed to the annual value of -$1.5 billion for FY2024, which is 169759.04% down from last year.
  • Latest data reveals that Elanco Animal Health reported Cash from Financing Activities of -$153.0 million as of Q3 2025, which was up 8858.21% from -$156.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Cash from Financing Activities ranged from a high of $231.0 million in Q3 2021 and a low of -$1.3 billion during Q3 2024
  • In the last 5 years, Elanco Animal Health's Cash from Financing Activities had a median value of -$84.0 million in 2022 and averaged -$114.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 34444.44% in 2021, then plummeted by 1010000.0% in 2022.
  • Over the past 5 years, Elanco Animal Health's Cash from Financing Activities (Quarter) stood at $44.0 million in 2021, then plummeted by 290.91% to -$84.0 million in 2022, then plummeted by 65.48% to -$139.0 million in 2023, then skyrocketed by 76.98% to -$32.0 million in 2024, then tumbled by 378.12% to -$153.0 million in 2025.
  • Its Cash from Financing Activities stands at -$153.0 million for Q3 2025, versus -$156.0 million for Q2 2025 and $52.0 million for Q1 2025.